DE60045446D1 - Perkutane resorbierbare zubereitungen - Google Patents

Perkutane resorbierbare zubereitungen

Info

Publication number
DE60045446D1
DE60045446D1 DE60045446T DE60045446T DE60045446D1 DE 60045446 D1 DE60045446 D1 DE 60045446D1 DE 60045446 T DE60045446 T DE 60045446T DE 60045446 T DE60045446 T DE 60045446T DE 60045446 D1 DE60045446 D1 DE 60045446D1
Authority
DE
Germany
Prior art keywords
percutaneous
salt
basic substance
addition salt
form acidic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60045446T
Other languages
English (en)
Inventor
Yasunori Takada
Koji Tanaka
Yasuhiro Ikeura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hisamitsu Pharmaceutical Co Inc
Original Assignee
Hisamitsu Pharmaceutical Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co Inc filed Critical Hisamitsu Pharmaceutical Co Inc
Application granted granted Critical
Publication of DE60045446D1 publication Critical patent/DE60045446D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Botany (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60045446T 1999-07-15 2000-07-11 Perkutane resorbierbare zubereitungen Expired - Lifetime DE60045446D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP20134099 1999-07-15
PCT/JP2000/004609 WO2001005381A1 (fr) 1999-07-15 2000-07-11 Preparations a absorption percutanee

Publications (1)

Publication Number Publication Date
DE60045446D1 true DE60045446D1 (de) 2011-02-10

Family

ID=16439413

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60045446T Expired - Lifetime DE60045446D1 (de) 1999-07-15 2000-07-11 Perkutane resorbierbare zubereitungen

Country Status (14)

Country Link
US (1) US7615237B1 (de)
EP (1) EP1197209B1 (de)
JP (1) JP4627945B2 (de)
KR (1) KR100686527B1 (de)
CN (1) CN1361686A (de)
AT (1) ATE493121T1 (de)
AU (1) AU771637B2 (de)
BR (1) BRPI0012401B1 (de)
CA (1) CA2379147C (de)
DE (1) DE60045446D1 (de)
DK (1) DK1197209T3 (de)
ES (1) ES2356704T3 (de)
TW (1) TWI234470B (de)
WO (1) WO2001005381A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4865958B2 (ja) * 2001-05-23 2012-02-01 株式会社トクホン 鎮痛抗炎症局所作用型の貼付剤
DE60236084D1 (de) * 2001-05-31 2010-06-02 Hisamitsu Pharmaceutical Co Perkutan resorbierbare pflaster
TWI327074B (en) * 2003-05-07 2010-07-11 Hisamitsu Pharmaceutical Co Ultra violet shielding patch
WO2006051818A1 (ja) * 2004-11-10 2006-05-18 Hisamitsu Pharmaceutical Co., Inc. 外用製剤及び貼付剤
WO2007007863A1 (en) * 2005-07-08 2007-01-18 Senju Pharmaceutical Co., Ltd. Percutaneously absorptive ophthalmic preparation comprising olopatadine
CN100420726C (zh) * 2005-09-19 2008-09-24 上海安立霸电器有限公司 医用热熔压敏胶型基质及制备
JP4869697B2 (ja) * 2005-12-08 2012-02-08 日東電工株式会社 外用剤
US8524273B2 (en) 2006-02-28 2013-09-03 Hisamitsu Pharmaceutical Co., Inc. Transdermal absorption preparation
DE102006054732B4 (de) * 2006-11-21 2010-12-30 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System mit Ionenpaar-Mikroreservoiren
WO2009048027A1 (ja) * 2007-10-09 2009-04-16 Arkray, Inc. 免疫関連遺伝子の多型の検出用プローブおよびその用途
JP5333972B2 (ja) 2007-11-22 2013-11-06 株式会社 メドレックス 脂肪酸系イオン液体を有効成分とする外用剤組成物
CN102341124A (zh) * 2009-03-11 2012-02-01 兴和株式会社 含有镇痛-抗炎症剂的外用剂
CN102341122A (zh) * 2009-03-11 2012-02-01 兴和株式会社 含有镇痛-抗炎症剂的外用剂
JP6131523B2 (ja) * 2011-03-25 2017-05-24 大正製薬株式会社 ロキソプロフェン含有外用剤
JP5878715B2 (ja) * 2011-09-22 2016-03-08 久光製薬株式会社 貼付剤
US8617579B2 (en) * 2012-04-16 2013-12-31 Conopco, Inc. Pre-blended mixtures of specific naturally sourced liquid materials structured with naturally sourced high melting point structuring material
GB201301774D0 (en) * 2013-01-31 2013-03-20 Henry Richard Composition
EP2926832A1 (de) * 2014-03-31 2015-10-07 Sanovel Ilac Sanayi ve Ticaret A.S. Pharmazeutische formulierungen von loxoprofen zur topischen anwendung
CN104288167B (zh) * 2014-10-29 2017-08-25 马应龙药业集团股份有限公司 一种治疗痔疮的七叶皂苷钠制剂及其制备方法
WO2017034027A1 (ja) * 2015-08-27 2017-03-02 東洋インキＳｃホールディングス株式会社 貼付剤
CN105693556A (zh) * 2016-03-01 2016-06-22 巴斯特医药科技（常州）有限公司 卡巴拉汀酒石酸盐的转化方法及其产物制成的贴片

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59164715A (ja) 1983-03-09 1984-09-17 Nitto Electric Ind Co Ltd 外用部材の製法
JPS59164714A (ja) 1983-03-09 1984-09-17 Sekisui Chem Co Ltd 治療用接着テ−プもしくはシ−ト
JPS6112621A (ja) 1984-06-27 1986-01-21 Lion Corp パツプ剤
JPS61260026A (ja) 1985-05-14 1986-11-18 Showa Denko Kk 経皮吸収性を高めた皮膚外用剤
JPH04217925A (ja) 1990-03-27 1992-08-07 Nippon Saafuakutanto Kogyo Kk 新規な解熱消炎鎮痛剤組成物
JP2849937B2 (ja) * 1990-04-18 1999-01-27 日東電工株式会社 医療用貼付剤
US5120545A (en) * 1990-08-03 1992-06-09 Alza Corporation Reduction or prevention of sensitization to drugs
JPH06112621A (ja) * 1992-09-29 1994-04-22 Fujitsu Ltd モジュールのスタンドオフ構造
JP2569396B2 (ja) 1992-12-04 1997-01-08 株式会社太平洋 経皮投与型薬物用貼付剤
US5340572A (en) * 1993-02-08 1994-08-23 Insite Vision Incorporated Alkaline ophthalmic suspensions
EP0788794A4 (de) 1994-08-09 2000-06-28 Tsumura & Co Mittel zur externen anwendung
US5968533A (en) * 1994-11-15 1999-10-19 Porter; Steven S. Skin care compositions and methods
JP3908795B2 (ja) 1994-11-29 2007-04-25 久光製薬株式会社 ケトチフェン含有経皮投与製剤
KR100277803B1 (ko) 1995-03-10 2001-01-15 가나이 쓰도무 3차원 그래픽 표시장치
DE69614942T2 (de) * 1995-07-04 2002-04-04 Kowa Co Hydrophiles Klebemittel
CN1167436A (zh) * 1995-09-07 1997-12-10 大制药株式会社 低压泡滕片剂
KR19990082208A (ko) * 1996-02-07 1999-11-25 오이시 고지 디클로페낙 나트륨의 투명 수용액 및 이를 이용한 의약 조성물
JPH09316007A (ja) 1996-05-31 1997-12-09 Advanced Sukin Res Kenkyusho:Kk 局所適用組成物
JP3725613B2 (ja) 1996-06-13 2005-12-14 積水化学工業株式会社 外用貼付剤
JP3672205B2 (ja) 1996-10-08 2005-07-20 東光薬品工業株式会社 皮膚低刺激性経皮吸収貼付剤
JP4275751B2 (ja) 1996-12-27 2009-06-10 久光製薬株式会社 外用組成物
JPH10316560A (ja) 1997-05-21 1998-12-02 Toko Yakuhin Kogyo Kk 貼付剤
JP4181232B2 (ja) * 1997-07-18 2008-11-12 帝國製薬株式会社 ジクロフェナクナトリウム含有油性外用貼付製剤
KR19990026792A (ko) * 1997-09-26 1999-04-15 김윤 디클로페낙 디에틸암모늄염을 함유한 매트릭스형 패취제제

Also Published As

Publication number Publication date
EP1197209B1 (de) 2010-12-29
JP4627945B2 (ja) 2011-02-09
CN1361686A (zh) 2002-07-31
EP1197209A4 (de) 2005-01-05
AU771637B2 (en) 2004-04-01
KR100686527B1 (ko) 2007-02-27
DK1197209T3 (da) 2011-04-04
TWI234470B (en) 2005-06-21
ES2356704T3 (es) 2011-04-12
KR20020015342A (ko) 2002-02-27
BRPI0012401B1 (pt) 2016-09-27
BR0012401A (pt) 2002-05-21
EP1197209A1 (de) 2002-04-17
WO2001005381A1 (fr) 2001-01-25
CA2379147A1 (en) 2001-01-25
CA2379147C (en) 2009-09-01
US7615237B1 (en) 2009-11-10
ATE493121T1 (de) 2011-01-15
AU5852100A (en) 2001-02-05

Similar Documents

Publication Publication Date Title
DE60045446D1 (de) Perkutane resorbierbare zubereitungen
ATE485815T1 (de) Zubereitungen zur perkutanen absorption
DE69529228D1 (de) Pflaster des matrixtyps
BRPI0307117B8 (pt) amidas de ácido antranílico e seus derivados, bem como seus usos como compostos ativos cosméticos e farmacêuticos
PT1295600E (pt) Medicamento com base em gestagenios que contem acido ascorbico e/ou sais do mesmo para uma aplicacao dermica
WO2001089571A3 (en) Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives
SE8504945L (sv) Farmaceutiska kompositioner innehallande antracyklinglykosider
DK0582239T3 (da) Farmaceutisk og/eller kosmetisk formulering
PT1069892E (pt) Sistema terapeutico activavel pela humidade
NO934706D0 (no) Substituerte 4-fenyl-pyridoner og 4-fenyl-2-alkoksypyridiner
EP0974363A4 (de) Heilmittel für die drogenabhängigkeit
KR890015742A (ko) 이병치료용 국소 제제
BR0312814A (pt) Levamisol / avermectinas ou similares em solvente de pirrolidona
FI885377A0 (fi) Foerfarande foer framstaellning av nya metronidazolsammansaettningar foer lokal administration.
AU5647199A (en) Carboxylic acid derivatives and drugs containing the same as the active ingredient
AU2001234107A1 (en) Benzoic acid derivatives, process for producing the same and drugs containing the same as the active ingredient
AU3669700A (en) 4-aminobutanoic acid derivatives and drugs containing these derivatives as the active ingredient
CA2380757A1 (en) Pharmaceutical agent comprising a benzamide derivative as active ingredient
EE9400296A (et) Piperidinüültioindooli derivaadid, ravimvormid, aktiivne valuvaigisti, nende valmistamise meetodid
ATE497764T1 (de) Perkutane absorptionszubereitungen mit 3-methyl-1-phenyl-2-pyrazolin-5-on
EP1161945A3 (de) Pharmazeutische Zusammensetzung enthaltend Prolin, Glycin und Lysin zur Behandlung von Sehnenverletzungen und offenen Wunden
MX9202273A (es) Derivados de piridona aminoacido azetidinil substituidos, su preparacion y su aplicacion como medicamentos.
WO2004004705A3 (en) Pharmaceutical formulations for preparing drink products
WO2003013613A1 (fr) Preparation medicinale a absorption percutanee
KR890009396A (ko) 경피 흡수 제제